Protease activated cytokines
作者： John Puskas , Mark Sullivan , John G. Frelinger , Baek Kim
DOI:
关键词: Biology 、 Protease 、 Nucleic acid 、 Biochemistry 、 Cancer
摘要: Provided herein are chimeric nucleic acid sequences encoding polypeptides. Also provided Further methods of treating a subject with or at risk developing cancer. The comprise selecting cancer, and administering to the an effective amount polypeptides herein.
lens.org 参考文章(80)
McAdam Aj, Lord Em, Frelinger Jg, Woods Ml, Isolation and expansion of tumor-infiltrating lymphocytes. BioTechniques. ,vol. 15, pp. 970- 972 ,(1993)
McKarney I, Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer. Issues in emerging health technologies. pp. 1- 4 ,(2007)
M Shirasu, M Shimotsuma, A Hagiwara, T Takahashi, MW Simpson-Morgan, A Sakuyama, JW Shields, Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology. ,vol. 26, pp. 90- 101 ,(1993)
Manuel L. Penichet, Eric T. Harvill, Sherie L. Morrison, Antibody-IL-2 fusion proteins: A novel strategy for immune potentiation Human antibodies. ,vol. 8, pp. 106- 118 ,(1997) , 10.3233/HAB-1997-8301
Kendall A Smith, The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs Medical Immunology. ,vol. 5, pp. 3- 3 ,(2006) , 10.1186/1476-9433-5-3
Justin Hanes, Allen Sills, Zhong Zhao, Kwang Wook Suh, Betty Tyler, Francesco DiMeco, Daniel J. Brat, Michael A. Choti, Kam W. Leong, Drew M. Pardoll, Henry Brem, Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharmaceutical Research. ,vol. 18, pp. 899- 906 ,(2001) , 10.1023/A:1010963307097
Peter P. Lee, Cassian Yee, Peter A. Savage, Lawrence Fong, Dirk Brockstedt, Jeffrey S. Weber, Denise Johnson, Susan Swetter, John Thompson, Philip D. Greenberg, Mario Roederer, Mark M. Davis, Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nature Medicine. ,vol. 5, pp. 677- 685 ,(1999) , 10.1038/9525
Paolo Dellabona, Mirella Giovarelli, Marco Forni, Tiziana Musso, Alessandra Allione, Patrizia Nanni, Bernd Gansbacher, Alberto Gulino, Guido Forni, Federica Cavallo, Mario P. Colombo, Hanno Hock, Pier Luigi Lollini, Felicia M. Rosenthal, Manuela Consalvo, Thomas Blankenstein, Luca Gusella, Maria C. Bosco, Immunizing and Curative Potential of Replicating and Nonreplicating Murine Mammary Adenocarcinoma Cells Engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, Tumor Necrosis Factor α, Granulocyte-Macrophage Colony-stimulating Factor, and γ-Interferon Gene or Admixed with Conventional Adjuvants Cancer Research. ,vol. 54, pp. 6022- 6026 ,(1994)
Harald Wajant, Thomas Wuest, Dieter Moosmayer, Klaus Pfizenmaier, Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) ,(2001)
Craig L. Slingluff, Kimberly A. Chianese‐Bullock, Timothy N.J. Bullock, William W. Grosh, David W. Mullins, Lisa Nichols, Walter Olson, Gina Petroni, Mark Smolkin, Victor H. Engelhard, Immunity to melanoma antigens: from self-tolerance to immunotherapy. Advances in Immunology. ,vol. 90, pp. 243- 295 ,(2006) , 10.1016/S0065-2776(06)90007-8